Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Emergent BioSolutions

Emergent BioSolutions reported $100K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Akebia Therapeutics AKBA:US USD 2K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
Amarin AMRN:US USD 301.28M 2.28M
ANI Pharmaceuticals ANIP:US USD 1000 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Chimerix CMRX:US USD 89K 1000
Coherus Biosciences CHRS:US USD 8K 0
Emergent BioSolutions EBS:US USD 100K 0
Exact Sciences EXAS:US USD 1.8M 19K
Exelixis EXEL:US USD 325K 1000
Glaxosmithkline GSK:US GBP 1.35B 1000K
Heron Therapeutics HRTX:US USD 1.19M 2K
Immunogen IMGN:US USD 2.26M 1000
Intercept Pharmaceuticals ICPT:US USD 42K 0
Ionis Pharmaceuticals IONS:US USD 143K 1000
Ironwood Pharmaceuticals IRWD:US USD 155K 1000
Lonza Group LONN:SW CHF 74M 0
Moderna Inc MRNA:US USD 38.4K 100
Myriad Genetics MYGN:US USD 800K 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Pacira PCRX:US USD 46K 0
PTC Therapeutics PTCT:US USD 73K 1000
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 0
United Therapeutics UTHR:US USD 700K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0